S

Systimmune

Develops bispecific antibodies and ADCs

Director/Senior Director - Clinical Development

Biology & BiotechConfirmed live in the last 24 hours
Full-timePrinceton, NJ, USA$230k - $300k /yrIn-person

About the Job

Requirements

  • An M.D. or equivalent is required; international degrees are accepted.
  • At least 2 years of experience in medical monitoring of oncology clinical trials, including Phase 1/2 trials.
  • Prior experience in clinical development or pharmaceutical/biotechnology settings.
  • A track record in product safety oversight and clinical trial execution, particularly with biologics such as antibody-drug conjugates and immuno-oncology agents.
  • A strong foundation in clinical and drug development processes.
  • Sound medical judgment and expertise in interpreting medical safety data.

Responsibilities

  • Lead the design and implementation of clinical development programs grounded in medical and scientific principles, regulatory knowledge, and business objectives.
  • Provide strategic medical input across the product lifecycle, from early development through Phase 3, for internal and partnered programs.
  • Oversee clinical trial execution and integrity; collaborate with Clinical Operations to manage enrollment progress, timelines, and key milestones.
  • Monitor trial safety with the Safety team and ensure compliance with serious adverse event reporting requirements.
  • Drive development and scientific accuracy of clinical documents, including protocols, Investigator Brochures, Clinical Study Reports, regulatory submissions, and response packages.
  • Serve as medical lead on clinical study teams, align medical strategy across functions, represent the clinical function in regulatory interactions, and ensure adherence to Good Clinical Practice, pharmacovigilance standards, standard operating procedures, and global compliance requirements.
  • Provide in-house clinical expertise on assigned compounds and indications.
  • Engage investigators and opinion leaders to inform development strategy and protocol design.
  • Stay current on therapeutic-area developments through continuous learning and participation in scientific forums.

Desired Qualifications

  • Phase 3 clinical trial experience is preferred.

About the Company

Systimmune

Develops bispecific antibodies and ADCs

Systimmune is a biopharmaceutical company that develops antibody-based cancer therapies, including bispecific and trispecific antibodies and antibody-drug conjugates (ADCs). These products are designed to act on the solid tumor micro-environment to directly attack tumors and/or to activate the immune system to fight cancer. The company uses multiple immuno-oncology platforms and experienced scientists to create biologics that intervene in the tumor environment in systematic ways. Compared with competitors, Systimmune emphasizes integrating several antibody-based modalities (bispecifics, trispecifics, and ADCs) and a deep focus on the solid tumor micro-environment, aiming to translate biological insight into targeted, immune-engaging therapies. The goal is to produce biologics that effectively modulate the tumor environment and mobilize the body's own immune response to destroy cancer cells.

Company size
11-50
Company stage
Not listed
Total funding
Not listed
Headquarters
Redmond, WA
Founded
2014

Recently Posted Jobs

Explore more opportunities at Systimmune

See more jobs